SHAH CAPITAL MANAGEMENT

Position in NVAX — Novavax Inc

CIK 1383838 RALEIGH, NC

Position in NVAX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$133,439,735

+$12,600,646 QoQ

Shares Held

14,165,577

-4.6% QoQ

Ownership

8.59%

of shares outstanding

% of Portfolio

26.48%

of 13F equity value

Holder Rank

of 263 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SHAH CAPITAL MANAGEMENT holds $133,439,735 across 1 Biotechnology name. NVAX ranks #1 (100.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	NVAX	Novavax Inc This page	14,165,577	$133,439,735

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$133,439,735	14,165,577	-4.6%	Shares	Sole	2026-08-14
2026-05-14	$137,582,491	14,714,705	-0.0%	Shares	Sole	2026-05-15
2026-04-08	$123,940,193	14,719,738	+9.9%	Shares	Sole	2026-04-08
2026-03-31	$120,839,089	14,845,097	+2.0%	Shares	Sole	2026-04-24
2025-12-31	$97,835,001	14,558,780	+23.3%	Shares	Sole	2026-01-15
2025-11-10	$95,220,838	13,392,523	+14.1%	Shares	Sole	2025-11-12
2025-10-13	$101,220,548	11,742,523	—	Shares	Sole	2025-10-14
2025-09-30	$102,408,132	11,811,780	+2.6%	Shares	Sole	2025-11-12
2025-06-30	$72,524,214	11,511,780	+3.4%	Shares	Sole	2025-07-23
2025-03-31	$71,355,132	11,131,846	-0.2%	Shares	Sole	2025-05-14
2024-12-31	$89,636,721	11,148,846	+13.6%	Shares	Sole	2025-01-22
2024-09-30	$123,970,282	9,815,541	+1.6%	Shares	Sole	2024-10-15
2024-06-30	$122,322,059	9,662,090	+19.0%	Shares	Sole	2024-08-12
2024-03-31	$38,803,213	8,117,827	+4.3%	Shares	Sole	2024-05-15
2023-12-31	$37,347,628	7,780,756	+22.9%	Shares	Sole	2024-02-05
2023-09-30	$45,834,673	6,330,756	+15.5%	Shares	Sole	2023-10-11
2023-06-30	$40,722,017	5,480,756	+28.9%	Shares	Sole	2023-07-12
2023-03-31	$29,459,956	4,251,076	+494.6%	Shares	Sole	2023-05-08
2022-12-31	$7,350,200	715,000	—	Shares	Sole	2023-01-13
No filing history on record for this holder in this stock.